The Clinical Epilepsy Section has been developing and testing new techniques to improve seizure control, medication tolerance, and rehabilitation in patients with severe epilepsy. Patients with uncontrolled seizures are admitted for a complete evaluation, including simultaneous video and telemetered electroencephalographic (EEG) recording of seizures, daily determinations of antiepileptic drug serum concentrations, positron emission tomography (PET), magnetic resonance imaging (MRI), and magnetoencephalography (MEG). A specific seizure diagnosis is established allowing each patient to be assigned to an appropriate research protocol and therapy. PET in patients with localized brain lesions has demonstrated focal hypometabolic cerebral areas corresponding to the interictal seizure EEG focus. In some patients, PET has been able to detect a focus when other methods have failed. Studies of patients during partial seizures have shown a change from hypo- to hypermetabolism at the site of the focus. In the Lennox-Gastaut syndrome, PET has revealed the existence of two separate metabolic patterns despite clinical seizure similarity. PET studies allow more definitive identification of the epileptic lesion and suggest new avenues of investigation into the basic mechanisms of the epilepsies. MRI may show small structural lesions underlying PET hypometabolism even when computed tomography (CT) is normal. Further studies will elucidate the relation of metabolic and pathologic changes. MEG may have the potential to accurately localize the subsurface origin of spikes. EEG provides little information on the spatial distribution of epileptiform discharges in cortical depths; MEG may be superior. Comparison of invasive localization of epileptic foci using subdural electrodes and noninvasive evaluation is being performed. After surgery, patients are followed with serial clinical, neuropsychological, and electroencephalographic evaluation. Children with partial seizures are followed with serial PET scans to assess the development of hypometabolism in the epileptic focus. The effect of the ketogenic diet is also being studied.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Intramural Research (Z01)
Project #
1Z01NS002236-14
Application #
3860776
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
1991
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Hirvonen, Jussi; Kreisl, William C; Fujita, Masahiro et al. (2012) Increased in vivo expression of an inflammatory marker in temporal lobe epilepsy. J Nucl Med 53:234-40
Giovacchini, Giampiero; Conant, Shielah; Herscovitch, Peter et al. (2009) Using cerebral white matter for estimation of nondisplaceable binding of 5-HT1A receptors in temporal lobe epilepsy. J Nucl Med 50:1794-800
Burstein, Aaron H; Boudreau, Eilis A; Theodore, William H (2009) Increase in tiagabine serum concentration with coadministration of gemfibrozil. Ann Pharmacother 43:379-82
Lim, Young-Min; Cho, Yong-Won; Shamim, Sadat et al. (2008) Usefulness of pulsed arterial spin labeling MR imaging in mesial temporal lobe epilepsy. Epilepsy Res 82:183-9
Theodore, William H; Epstein, Leon; Gaillard, William D et al. (2008) Human herpes virus 6B: a possible role in epilepsy? Epilepsia 49:1828-37
Hasler, Gregor; Bonwetsch, Robert; Giovacchini, Giampiero et al. (2007) 5-HT1A receptor binding in temporal lobe epilepsy patients with and without major depression. Biol Psychiatry 62:1258-64
Fotheringham, Julie; Donati, Donatella; Akhyani, Nahid et al. (2007) Association of human herpesvirus-6B with mesial temporal lobe epilepsy. PLoS Med 4:e180
Harden, C L; Huff, J S; Schwartz, T H et al. (2007) Reassessment: neuroimaging in the emergency patient presenting with seizure (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 69:1772-80
Theodore, William H; Hasler, Gregor; Giovacchini, Giampiero et al. (2007) Reduced hippocampal 5HT1A PET receptor binding and depression in temporal lobe epilepsy. Epilepsia 48:1526-30
Theodore, W H; Fisher, R (2007) Brain stimulation for epilepsy. Acta Neurochir Suppl 97:261-72

Showing the most recent 10 out of 68 publications